has anyone died from glp-1 Real-world weight loss effectiveness of agonists among patients with type 2 diabetes: a retrospective cohort study Weaning off a GLP-1? Tips

SURPASS-CVOT is unique, in that it compares the dual incretin agonist with a GLP-1 RA that has been shown to have cardiovascular benefit in people with type 2 diabetes and high risk ASCVD

You'll likely see your healthcare provider for regular check-ups to make sure the drug is working, monitor for possible side effects, and make dosing adjustments as needed

But over time, I found myself asking a different one: If this medication is helping me lose weight, keep it off, and improve my blood sugar, and it is safe for me, why would I stop? Is microdosing safe

Liver function is another important safety checkpoint: naltrexone is hepatically metabolized, as are many medications used alongside weight loss therapy